Artiva Biotherapeutics所有资讯

Artiva Biotherapeutics | 4：持股变动声明-董事 MOORE ALISON

10/22 20:23 (美东)

Artiva Biotherapeutics | 3：首次持股声明-董事 MOORE ALISON

10/22 20:18 (美东)

Artiva Biotherapeutics | 8-K：重大事件

10/22 16:18 (美东)

Artiva Biotherapeutics | 4：持股变动声明-高管 Raymon Heather

09/13 16:18 (美东)

Artiva Biotherapeutics | 4：持股变动声明-高管 Graef Thorsten

09/13 16:18 (美东)

Artiva Biotherapeutics | 4：持股变动声明-高管 Horan Christopher

09/13 16:18 (美东)

Artiva Biotherapeutics | 4：持股变动声明-高管 Bush Jennifer

09/13 16:17 (美东)

Artiva Biotherapeutics | 4：持股变动声明-高管 Krishnamohan Neha

09/13 16:17 (美东)

Artiva Biotherapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(40.6%),Peter Kolchinsky(40.6%)等

09/03 16:22 (美东)

Artiva Biotherapeutics | 10-Q：季度报表

08/29 16:23 (美东)

Artiva Biotherapeutics | 8-K：Artiva Biotherapeutics公布2024年第二季度财务业绩和近期业务亮点

08/29 16:22 (美东)

Artiva Biotherapeutics | SC 13G：超过5%持股股东披露文件-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%)等

08/01 19:01 (美东)

Artiva Biotherapeutics | SC 13G：超过5%持股股东披露文件-Andrew J. Schwab(10.1%),Kush Parmar(10.1%)等

08/01 16:23 (美东)

Artiva Biotherapeutics | SC 13G：超过5%持股股东披露文件-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%)等

08/01 16:22 (美东)

Artiva Biotherapeutics | SC 13D：超过5%持股股东披露文件-RA Capital Management, L.P.(42.3%),Peter Kolchinsky(42.3%)等

07/29 16:31 (美东)

Artiva Biotherapeutics | SC 13D：超过5%持股股东披露文件-GC Corp.(19.6%),Yong-Jun Huh(19.6%)等

07/29 16:21 (美东)

Artiva Biotherapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.

07/24 16:31 (美东)

Artiva Biotherapeutics | 4：持股变动声明-股东 5AM Partners VI, LLC

07/24 16:20 (美东)

Artiva Biotherapeutics | 4：持股变动声明-股东 Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

07/22 20:32 (美东)

Artiva Biotherapeutics | 4：持股变动声明-股东 venBio Global Strategic Fund III, L.P.

07/22 20:27 (美东)